Controversies in Drugs Policy and Practice


Book Description

The rapid deepening of the global drug problem has spurred increasingly heated debate over the best solutions. For example, should drug use be an issue for healthcare services or a matter of criminal justice? Is universal abstinence both unrealistic and undesirable? Does drug legalization offer a viable answer? This book provides a lively and thought-provoking account of some of the most pressing issues for policy makers and practitioners in the debate about drugs. Designed as a platform for further discussion, it presents the full spectrum of perspectives on chronic and contemporary challenges to drug policy and explores the reality for drug users, dealers, suppliers and producers. Drawing on an international evidence base, the author considers: - Drug enforcement measures: do they work and are they always ethical? - Addiction treatment: its purpose, cost and limitations - Drug research: the strength of its impact on policy and practice - Possible solutions: from classic criminalization to radical harm reduction Both engaging and timely, Controversies in Drugs Policy and Practice is an essential read for all social science students taking modules related to drug use, addiction and treatment. It also makes illuminating reading for academics and practitioners working within the field.




Fixing Drugs


Book Description

In this unique and engaging book, Sue Pryce tackles the major issues surrounding drug policy. Why do governments persist with prohibition policies, despite their proven inefficacy? Why are some drugs criminalized, and some not? And why does society care about drug use at all? Pryce guides us through drug policy around the world.




Federal Drug Control


Book Description

A comprehensive look at the beginnings of the current drug problems in the United States Federal Drug Control: The Evolution of Policy and Practice presents an overview of the key issues and key individuals responsible for the creation of the federal government’s efforts to control illegal drugs in the United States, from 1875-2001. The book focuses special attention on federal legislation that constructed the federal drug regulatory machinery and the Supreme Court cases that interpreted these laws and their implementation. An esteemed panel of scholars, including co-editor Joseph Spillane, author of Cocaine: From Medical Marvel to Modern Menace, and William B. McAllister, author of Drug Diplomacy in the Twentieth Century: An International History, traces the internal tensions between factions favoring medicalization and criminalization throughout the 20th century, examining the difficult choices that continue to be made in this ongoing debate. The central question in the government’s response to the crisis of illicit drugs in the United States has remained the same for more than 125 years: Should the government rely on educational and treatment programs or turn to the criminal justice system for answers? Federal Drug Control examines the historic turning points of the debate, including the 19th Century origins of the controversy, legislation and subsequent Supreme Court decisions in the 20th Century, international attempts at drug control agreements, and the emergence of new illicit drugs. The book also looks at the influential figures of the debate, including Levi Nutt, Lawrence Kolb, Richard Pearson Hobson, A.G. DuMez, and Harry J. Anslinger who ran the Federal Bureau of Narcotics (FBN) for more than 30 years. Federal Drug Control examines: the history of cocaine use in the 20th Century the history of marijuana use in the 20th Century the advent of psychotropic drugs in the 1960s the origins of the Harrison Narcotic Act the federal government’s efforts to limit the pharmacy profession’s control over prescription drugs and much more! Federal Drug Control: The Evolution of Policy and Practice is an essential resource for criminologists, historians, social historians, sociologists, anthropologists, public policymakers, academics, and anyone interested in the broad issues involved in how the federal government deals with the problem of illicit drugs in the United States.




Drugs and Drug Policy


Book Description

Drugs and Drug Policy: The Control of Consciousness Alteration provides a cross-national perspective on the regulation of drug use by examining and critiquing drug policies in the United States and abroad in terms of their scope, goals, and effectiveness. In this engaging text, authors Clayton J. Mosher and Scott Akins discuss the physiological, psychological, and behavioral effects of legal and illicit drugs; the patterns and correlates of use; and theories of the "causes" of drug use. Key Features: * Offers more coverage of drug policy issues than competitive books: This book addresses the number of significant developments over the last few decades that suggest the dynamics of drug use and policies to deal with drug use are at a critical juncture. The book also considers the issue of "American exceptionalism" with respect to drug policies through a detailed analysis of emerging drug polices in other Western nations. * Makes explicit comparisons between legal and illegal drugs: Due to their prevalence of use, this book devotes considerable attention to the use and regulation of legal drugs in society. The book illustrates that commonly prescribed medications are similar to drugs that are among the most feared and harshly punished in society and that drug-related problems do not necessarily result from particular drugs, but from how drugs are used. * Includes many pedagogical tools: With chapter opening photos and more photos throughout, this text presents material in a student- friendly fashion. Highlight boxes provide interesting examples for readers; encourage further emphasis on issues; and serve as important topics for in class writing exercises. In addition, Internet exercises and review questions reinforce key points made in the chapter and prompt classroom discussion.




Medications for Opioid Use Disorder Save Lives


Book Description

The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already existâ€"like evidence-based medicationsâ€"are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed.




Model Rules of Professional Conduct


Book Description

The Model Rules of Professional Conduct provides an up-to-date resource for information on legal ethics. Federal, state and local courts in all jurisdictions look to the Rules for guidance in solving lawyer malpractice cases, disciplinary actions, disqualification issues, sanctions questions and much more. In this volume, black-letter Rules of Professional Conduct are followed by numbered Comments that explain each Rule's purpose and provide suggestions for its practical application. The Rules will help you identify proper conduct in a variety of given situations, review those instances where discretionary action is possible, and define the nature of the relationship between you and your clients, colleagues and the courts.




The Health Effects of Cannabis and Cannabinoids


Book Description

Significant changes have taken place in the policy landscape surrounding cannabis legalization, production, and use. During the past 20 years, 25 states and the District of Columbia have legalized cannabis and/or cannabidiol (a component of cannabis) for medical conditions or retail sales at the state level and 4 states have legalized both the medical and recreational use of cannabis. These landmark changes in policy have impacted cannabis use patterns and perceived levels of risk. However, despite this changing landscape, evidence regarding the short- and long-term health effects of cannabis use remains elusive. While a myriad of studies have examined cannabis use in all its various forms, often these research conclusions are not appropriately synthesized, translated for, or communicated to policy makers, health care providers, state health officials, or other stakeholders who have been charged with influencing and enacting policies, procedures, and laws related to cannabis use. Unlike other controlled substances such as alcohol or tobacco, no accepted standards for safe use or appropriate dose are available to help guide individuals as they make choices regarding the issues of if, when, where, and how to use cannabis safely and, in regard to therapeutic uses, effectively. Shifting public sentiment, conflicting and impeded scientific research, and legislative battles have fueled the debate about what, if any, harms or benefits can be attributed to the use of cannabis or its derivatives, and this lack of aggregated knowledge has broad public health implications. The Health Effects of Cannabis and Cannabinoids provides a comprehensive review of scientific evidence related to the health effects and potential therapeutic benefits of cannabis. This report provides a research agendaâ€"outlining gaps in current knowledge and opportunities for providing additional insight into these issuesâ€"that summarizes and prioritizes pressing research needs.




The New Jim Crow


Book Description

One of the New York Times’s Best Books of the 21st Century Named one of the most important nonfiction books of the 21st century by Entertainment Weekly‚ Slate‚ Chronicle of Higher Education‚ Literary Hub, Book Riot‚ and Zora A tenth-anniversary edition of the iconic bestseller—"one of the most influential books of the past 20 years," according to the Chronicle of Higher Education—with a new preface by the author "It is in no small part thanks to Alexander's account that civil rights organizations such as Black Lives Matter have focused so much of their energy on the criminal justice system." —Adam Shatz, London Review of Books Seldom does a book have the impact of Michelle Alexander's The New Jim Crow. Since it was first published in 2010, it has been cited in judicial decisions and has been adopted in campus-wide and community-wide reads; it helped inspire the creation of the Marshall Project and the new $100 million Art for Justice Fund; it has been the winner of numerous prizes, including the prestigious NAACP Image Award; and it has spent nearly 250 weeks on the New York Times bestseller list. Most important of all, it has spawned a whole generation of criminal justice reform activists and organizations motivated by Michelle Alexander's unforgettable argument that "we have not ended racial caste in America; we have merely redesigned it." As the Birmingham News proclaimed, it is "undoubtedly the most important book published in this century about the U.S." Now, ten years after it was first published, The New Press is proud to issue a tenth-anniversary edition with a new preface by Michelle Alexander that discusses the impact the book has had and the state of the criminal justice reform movement today.




Addiction Debates


Book Description

Addiction Debates explores the tumultuous landscape of addiction research, policy and practice. Covering all the ′hot topics′ of the day in a balanced and informative manner, Comiskey provides international perspectives on each topic, stimulating debate and discussion via the different approaches taken globally. Considering the complexities of debates around legalisation, rehabilitation, abstinence, harm reduction, and the current opioid epidemic, this SAGE Swift also looks into the health and social concerns related to drug consumption. Less-often debated topics include the ageing population of people who use drugs, the rights of the child of parents who use drugs, and the pressure these unique factors put on public health and associated services. A relevant text for a range of disciplines and people, sure to inform, challenge and continue the debate.




Facing Addiction in America


Book Description

All across the United States, individuals, families, communities, and health care systems are struggling to cope with substance use, misuse, and substance use disorders. Substance misuse and substance use disorders have devastating effects, disrupt the future plans of too many young people, and all too often, end lives prematurely and tragically. Substance misuse is a major public health challenge and a priority for our nation to address. The effects of substance use are cumulative and costly for our society, placing burdens on workplaces, the health care system, families, states, and communities. The Report discusses opportunities to bring substance use disorder treatment and mainstream health care systems into alignment so that they can address a person's overall health, rather than a substance misuse or a physical health condition alone or in isolation. It also provides suggestions and recommendations for action that everyone-individuals, families, community leaders, law enforcement, health care professionals, policymakers, and researchers-can take to prevent substance misuse and reduce its consequences.